Search Results - "BONFIGLI, A. R"

Refine Results
  1. 1
  2. 2

    Leukocyte telomere length is associated with complications of Type 2 diabetes mellitus by Testa, R., Olivieri, F., Sirolla, C., Spazzafumo, L., Rippo, M. R., Marra, M., Bonfigli, A. R., Ceriello, A., Antonicelli, R., Franceschi, C., Castellucci, C., Testa, I., Procopio, A. D.

    Published in Diabetic medicine (01-11-2011)
    “…Diabet. Med. 28, 1388–1394 (2011) Objective  The key goal of diabetes management is to prevent complications. While the patho‐physiological mechanisms…”
    Get full text
    Journal Article
  3. 3

    Diabetes-related quality of life is enhanced by glycaemic improvement in older people by Abbatecola, A. M., Spazzafumo, L., Fabbietti, P., Testa, R., Rabini, R. A., Bonfigli, A. R., Corsonello, A., Lattanzio, F., Paolisso, G.

    Published in Diabetic medicine (01-02-2015)
    “…Aims To investigate the validity and reliability of the Audit of Diabetes‐Dependent Quality of Life instrument in older Italians with diabetes and to test the…”
    Get full text
    Journal Article
  4. 4

    Effect of etanercept on insulin sensitivity in nine patients with psoriasis by Marra, M, Campanati, A, Testa, R, Sirolla, C, Bonfigli, A R, Franceschi, C, Marchegiani, F, Offidani, A

    “…Metabolic syndrome is associated to chronic low grade inflammation, characterized by increased levels of inflammatory cytokines, such as Tumor Necrosis…”
    Get more information
    Journal Article
  5. 5

    Interleukin-6–174 G > C polymorphism affects the association between IL-6 plasma levels and insulin resistance in type 2 diabetic patients by Testa, R., Olivieri, F., Bonfigli, A.R., Sirolla, C., Boemi, M., Marchegiani, F., Marra, M., Cenerelli, S., Antonicelli, R., Dolci, A., Paolisso, G., Franceschi, C.

    Published in Diabetes research and clinical practice (01-03-2006)
    “…Interleukin-6 (IL-6), a powerful inflammatory mediator, plays a pivotal role in the pathogenesis of insulin resistance and type 2 diabetes. Recently, the IL-6…”
    Get full text
    Journal Article
  6. 6

    ZnT8 Arg325Trp polymorphism influences zinc transporter expression and cytokine production in PBMCs from patients with diabetes by Giacconi, R., Malavolta, M., Chiodi, L., Boccoli, G., Costarelli, L., Bonfigli, A.R., Galeazzi, R., Piacenza, F., Basso, A., Gasparini, N., Nisi, L., Testa, R., Provinciali, M.

    Published in Diabetes research and clinical practice (01-10-2018)
    “…ZnT8 Arg325Trp polymorphism has been associated with type 2 diabetes (T2DM) susceptibility. The Arg-325 risk variant shows accelerated zinc (Zn) transport…”
    Get full text
    Journal Article
  7. 7

    Hyperglycemia following recovery from hypoglycemia worsens endothelial damage and thrombosis activation in type 1 diabetes and in healthy controls by Ceriello, A, Novials, A, Ortega, E, Pujadas, G, La Sala, L, Testa, R, Bonfigli, A.R, Genovese, S

    “…Abstract Background and aims Hypoglycemia produces thrombosis activation, but little attention has been paid to the effects of hyperglycemia following recovery…”
    Get full text
    Journal Article
  8. 8

    Randomized, double-blind, placebo-controlled trial to evaluate the effect of Helicobacter pylori eradication on glucose homeostasis in type 2 diabetic patients by Bonfigli, A.R., Dr, Boemi, M, Festa, R, Bonazzi, P, Brandoni, G, Spazzafumo, L, Olivieri, F, Ceriello, A, Genovese, S, Testa, R

    “…Abstract Background and aims Literature data suggest an association between Helicobacter pylori infection and glucose homeostasis. However, a causative link…”
    Get full text
    Journal Article
  9. 9

    Helicobacter pylori masks differences in homocysteine plasma levels between controls and type 2 diabetic patients by Cenerelli, S., Bonazzi, P., Galeazzi, R., Testa, I., Bonfigli, A. R., Sirolla, C., Giunta, S., Galeazzi, L., Fumelli, D., Testa, R.

    Published in European journal of clinical investigation (01-03-2002)
    “…Background Data in the literature have not clarified whether type 2 diabetes mellitus affects homocysteine plasma levels. Different variables able to influence…”
    Get full text
    Journal Article
  10. 10

    647 A/C and +1245 MT1A polymorphisms in the susceptibility of diabetes mellitus and cardiovascular complications by Giacconi, R., Bonfigli, A.R., Testa, R., Sirolla, C., Cipriano, C., Marra, M., Muti, E., Malavolta, M., Costarelli, L., Piacenza, F., Tesei, S., Mocchegiani, E.

    Published in Molecular genetics and metabolism (01-05-2008)
    “…Diabetes mellitus is a chronic disease characterized by an overproduction of reactive oxygen species, which perturbs zinc metabolism and promotes the onset of…”
    Get full text
    Journal Article
  11. 11

    Age-dependent changes of serum oxygen radical scavenger capacity and haemoglobin glycosylation in non-insulin-dependent diabetic patients by Pieri, C, Testa, R, Marra, M, Bonfigli, A R, Manfrini, S, Testa, I

    Published in Gerontology (Basel) (01-03-2001)
    “…Contradictory results have been reported in the literature concerning the correlation between glycosylated haemoglobin (HbA1c) and peroxidation level in serum…”
    Get more information
    Journal Article
  12. 12

    Relationship between lipoprotein(a) levels, oxidative stress, and blood pressure levels in patients with essential hypertension by ANTONICELLI, R, TESTA, R, BONFIGLI, A. R, SIROLLA, C, PIERI, C, MARRA, M, MARCOVINA, S. M

    Published in Clinical and experimental medicine (01-09-2001)
    “…High plasma levels of lipoprotein(a) [Lp(a)] are considered a risk factor for the development of coronary artery disease. In vitro experiments have shown that…”
    Get full text
    Journal Article
  13. 13

    Determination of plasma Metformin by a new cation-exchange HPLC technique by BONFIGLI, A. R, MANFRINI, S, GREGORIO, F, TESTA, R, TESTA, I, DE SIO, G, COPPA, G

    Published in Therapeutic drug monitoring (01-06-1999)
    “…Metformin is an oral antihyperglycemic agent used in the therapy of noninsulin-dependent diabetic patients. This biguanide can induce dangerous complications…”
    Get full text
    Journal Article
  14. 14

    Relationship between plasminogen activator inhibitor type-1 plasma levels and the lipoprotein(a) concentrations in non-insulin-dependent diabetes mellitus by Testa, R., Bonfigli, A.R., Piantanelli, L., Manfrini, S., Testa, I., Gregorio, F.

    Published in Diabetes research and clinical practice (01-07-1996)
    “…The first part of the paper deals with the relationship between two inhibiting factors of the complex enzyme cascade regulating fibrinolysis, namely…”
    Get full text
    Journal Article
  15. 15

    Increased expression of 5-lipoxygenase is common in clear cell renal cell carcinoma by Faronato, M, Muzzonigro, G, Milanese, G, Menna, C, Bonfigli, A R, Catalano, A, Procopio, A

    Published in Histology and histopathology (01-10-2007)
    “…The clinical behaviour of Clear Cell Renal Cell Carcinoma (CC-RCC) is often unpredictable. To fully understand the signaling pathways involved in CC-RCC…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Risk profiles in type 2 diabetes (metabolic syndrome): integration of IL-10 polymorphisms and laboratory parameters to identify vascular damages related complications by Forte, G I, Pilato, G, Vaccarino, L, Sanacore, M, Candore, G, Romano, G C, Testa, R, Franceschi, C, Capri, M, Marra, M, Bonfigli, A R, Caruso, C, Scola, L, Lio, D

    Published in Current pharmaceutical design (01-03-2010)
    “…Recently it has been reported that low serum IL-10 levels are associated with an increased susceptibility for metabolic syndrome and type 2 diabetes mellitus…”
    Get more information
    Journal Article
  18. 18

    C-reactive protein is directly related to plasminogen activator inhibitor type 1 (PAI-1) levels in diabetic subjects with the 4G allele at position −675 of the PAI-1 gene by Testa, R, Bonfigli, A.R, Sirolla, C, Marra, M, Boemi, M, Mari, D, Sacchi, E, Dolci, A, Catalano, A, Procopio, A, Ceriello, A

    “…Abstract Background and aims C-reactive protein (CRP) has been identified as a possible factor able to promote atherosclerosis. “In vitro” studies have…”
    Get full text
    Journal Article
  19. 19

    Vitamin E intake reduces plasminogen activator inhibitor type 1 in T2DM patients by Bonfigli, A R, Pieri, C, Manfrini, S, Testa, I, Sirolla, C, Ricciotti, R, Marra, M, Compagnucci, P, Testa, R

    Published in Diabetes, nutrition & metabolism (01-04-2001)
    “…Previous studies hypothesised that vitamin E could protect against coronary heart disease and vascular complications in diabetes, but no studies have been…”
    Get more information
    Journal Article
  20. 20

    Fibronectin and lipoprotein(a) are inversely related to plasminogen activator inhibitor type-1 levels in Type 2 diabetic patients without complications by Testa, R, Bonfigli, A R, Sirolla, C, De Grazia, G, Compagnucci, P, Manfrini, S, Fumelli, D, Testa, I

    Published in Diabetes, nutrition & metabolism (01-10-2000)
    “…Plasminogen activator inhibitor type-1 (PAI-1), the most important physiological fibrinolysis inhibitor, is considered an independent factor of cardiovascular…”
    Get more information
    Journal Article